Citations

Clear

7552 citation(s) found for "Ho, Matthew".

Physiological Glucocorticoid Replacement in Adrenal Insufficiency: Does It Fix the Broken Clock?
Brown, Matthew R, Matveyenko, Aleksey V. , Brown, Matthew , Brown, Matthew R , Brown, Matthew R

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | July 2, 2018 | Volume: 103 | Issue: 9 | Pages: 3511-3513

10.1210/jc.2018-01245 | PMID 29982538 Get It

Perioperative Medication Management: Reconciling Differences across Clinical Sites
Duncan, Benjamin J. , Furniss, Stephanie K, Solomon, Andrew , Burton, Matthew M., Poterack, Karl A. , Miksch, Timothy, Helmers, Richard A. , Zheng, Lu , Doebbeling, Bradley N. , Grando, Adela , Kaufman, David Ross

Mayo Clinic

Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care | June 29, 2018 | Volume: 7 | Issue: 1 | Pages: 44-51

10.1177/2327857918071010 Get It

Medication reconciliation (MedRec) is a mission-critical process which can serve to reduce adverse drug events (ADEs) in surgical settings. However, providing quality care is limited by current health information technology (IT), which is often inefficient and unintuitive due to poor usability, resulting in high cognitive burden. We have been characterizing EHR mediated workflow in the Mayo Clinic enterprise prior to a system-wide electronic health records (EHR) conversion in order to harmonize workflows. We compared and evaluated MedRec processes in pre-operative nursing assessments across two different EHRs in place in different locales at baseline. The interfaces differed both in their modes of interaction and cognitive support. Analyses surfaced interface elements that were unintuitive and inefficient, creating unnecessary complexities in clinicians’ interactive behavior. Keystroke level models (KLM), a modeling tool for predicting task completion time, showed that to access medication lists required a different series of operations across the two systems. Different designs can differentially mediate task performance, which can aid in the mitigation of errors for complex cognitive tasks. Identification of barriers in EHR-mediated workflow and barriers to interface usability could lead to system redesigns that minimize cognitive load while improving patient safety and efficiency.
A randomized controlled trial of fixed- versus mobile-bearing total knee arthroplasty
Tibbo, Meagan E. , Trousdale, R T, Hanssen, Arlen D. , Pagnano, Mark W. , Abdel, Matthew P. , Stuart, Michael J.

Mayo Clinic

The Bone & Joint Journal | June 29, 2018 | Volume: 100-B | Issue: 7 | Pages: 925-929

10.1302/0301-620x.100b7.bjj-2017-1473.r1 | PMID 29954199 Get It

AimsIt has been suggested that mobile-bearing total knee arthroplasty (TKA) might lead to better outcomes by accommodating some femorotibial rotational mismatch, thereby reducing contact stresses and polyethylene wear. The aim of this study was to determine whether there is a difference between fixed- and mobile-bearing versions of a contemporary TKA with respect to durability, range of movement (ROM) and function, ten years postoperatively.Patients and MethodsA total of 240 patients who were enrolled in this randomized controlled trial (RCT) underwent a primary cemented TKA with one of three tibial components (all-polyethylene fixed-bearing, modular metal-backed fixed-bearing and mobile-bearing). Patients were reviewed at a median follow-up of ten years (IQR 9.2 to 10.4).ResultsThere was no difference in durability, as measured by survivorship free of revision for any reason, nor in mean maximal ROM at ten years (p = 0.8). There was also no difference in function, as measured by Knee Society (KS) function scores (p = 0.63) or the prevalence of patellar tilt (p = 0.12).ConclusionIn this clinical RCT, the mobile-bearing design of TKA was found to be reliable and durable, but did not provide better maximum knee flexion, function or durability ten years postoperatively compared with a posterior-stabilized, fixed-bearing design incorporating either an all-polyethylene or a modular-metal-backed tibial component. Cite this article: Bone Joint J 2018;100-B:925–9.
Tau uptake in agrammatic primary progressive aphasia with and without apraxia of speech
Utianski, Rene L. , Whitwell, Jennifer L. , Botha, Hugo , Senjem, Matthew L. , Petersen, Ronald C. , Jack, Clifford R. , Lowe, Val J. , Josephs, Keith A. , Utianski, Rene L , Jack, Clifford R , Senjem, Matthew L , Botha, Hugo , Schwarz, Christopher G. , Duffy, Joseph R. , Clark, Heather M. , Machulda, Mary M. , Knopman, David S.

Mayo Clinic

European Journal of Neurology | June 23, 2018 | Volume: 25 | Issue: 11 | Pages: 1352-1357

10.1111/ene.13733 | PMID 29935044 Get It

Background and purposeThe non‐fluent/agrammatic variant of primary progressive aphasia (agPPA) is a heterogeneous diagnosis wherein some individuals have apraxia of speech (AOS). When agPPA includes AOS, a tauopathy is the likely underlying pathology. Recently, [18F]AV‐1451 was developed for the in‐vivo assessment of tau. In this study, we compared patterns of tau tracer uptake in patients with agPPA with and without AOS.MethodsNine patients with agPPA (four without AOS) underwent tau positron emission tomography imaging with [18F]AV‐1451. Uptake of [18F]AV‐1451 was assessed as cortical to cerebellar crus ratio (standard uptake value ratio) in cortical regions of interest measured using the MCALT atlas and compared voxel‐wise in SPM12. Each patient was age‐ and sex‐matched to three controls.ResultsThe agPPA without AOS showed uptake in the left frontal and temporal lobes, whereas agPPA with AOS showed uptake in the bilateral supplementary motor areas, frontal lobes, precuneus and precentral gyrus relative to controls. The left precentral gyrus had uptake in agPPA with AOS relative to those without AOS.ConclusionsThis cross‐sectional study suggests that [18F]AV‐1451 uptake in the precentral gyrus is implicated in AOS in agPPA.
IMMU-12. T-CELL THERAPIES DEMONSTRATE EFFICACY WITHOUT TOXICITY IN IMMUNOCOMPETENT MODELS OF BRAINSTEM TUMORS
Schuelke, Matt, Wongthida, Phonphimon , Thompson, Jill , Kottke, Tim , Sánchez-Pérez, Luis, Vile, Richard G. , Schuelke, Matthew , Evgin, Laura , Sampson, John Howard

Mayo Clinic

Neuro-Oncology | June 21, 2018 | Volume: 20 | Issue: suppl_2 | Pages: i101-i101

10.1093/neuonc/noy059.328 Get It

Intravenous Versus Topical Tranexamic Acid in Total Knee Arthroplasty
Abdel, Matthew P. , Taunton, Michael J. , Pagnano, Mark W. , Trousdale, Robert T. , Lee, Yuo-yu, Su, Edwin P. , Haas, Steven B., Figgie, Mark P. , Mayman, David J. , Chalmers, Brian P. , Abdel, Matthew P , Taunton, Michael J , Sierra, Rafael J. , Lee, Yuo-yu , Boettner, Friedrich

Mayo Clinic

Journal of Bone and Joint Surgery | June 20, 2018 | Volume: 100 | Issue: 12 | Pages: 1023-1029

10.2106/jbjs.17.00908 | PMID 29916929 Get It

Background: Tranexamic acid (TXA) reduces bleeding and the need for transfusion after total knee arthroplasty. Most literature has focused on intravenous (IV) administration of TXA, with less data available on the efficacy of topically administered TXA. This multicenter randomized clinical trial specifically assessed the efficacy of topical TXA compared with IV TXA as measured by calculated blood loss, drain output, and transfusion rates. Complications, including venous thromboembolism (VTE), were reported. Methods: A total of 640 patients who underwent primary unilateral total knee arthroplasty for osteoarthritis at 2 large academic centers were randomized to receive 1 g of IV TXA prior to tourniquet inflation and 1 g at closure, or 3 g of TXA diluted in 45 mL of normal saline solution (total volume of 75 mL) and topically applied after cementation. Age, sex, body mass index, American Society of Anesthesiologists (ASA) score, and preoperative hemoglobin level were similar between the groups. Univariate, multiple linear regression, and multiple logistic regression analyses were performed. Results: Patients who received topical TXA had significantly greater calculated blood loss compared with those who received IV TXA (mean of 324 compared with 271 mL; p = 0.005). Drain output was significantly higher in the topical TXA group compared with the IV TXA group (mean of 560 compared with 456 mL; p < 0.0001). The rate of transfusion was low in the topical and IV groups, with no significant difference on univariate analysis (1.6% compared with 0.6%, respectively; p = 0.45); however, on multiple logistic regression analysis, patients who received topical TXA were 2.2-fold more likely to receive a transfusion (p < 0.0001). The topical and IV TXA groups did not differ significantly with respect to the rate of thrombotic events (0.6% compared with 1.6%, respectively; p = 0.45). Conclusions: In this large, randomized clinical trial involving patients undergoing total knee arthroplasty, both IV and topical TXA were associated with a low rate of transfusion. While IV TXA was associated with less calculated blood loss, lower drain output, and fewer transfusions, the small differences between the groups may not be clinically important. Given the low prevalence of thrombotic complications, the relative safety of one formulation of TXA over the other cannot be definitely established. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
Incidence of Intralabyrinthine Schwannoma: A Population-based Study Within the United States
Marinelli, John P. , Lohse, Christine M. , Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | June 17, 2018 | Volume: 39 | Issue: 9 | Pages: 1191-1194

10.1097/mao.0000000000001875 | PMID 29912836 Get It

Objective: To describe the incidence of intralabyrinthine schwannoma (ILS) utilizing the Rochester Epidemiology Project (REP), a unique medical consortium in the United States that covers a complete population of all ages in a well-defined geographic area over the past half-century. Patients: All patients with ILS diagnosed between January 1, 1966 and December 31, 2016 in Olmsted County, Minnesota, identified using the REP medical records-linkage system. Main Outcome Measures: Incidence of ILS. Results: Fourteen incident cases of ILS were identified in Olmsted County since 1966—a period spanning 5.9 million person-years. Over the past decade, the incidence rate of ILS was 0.81 per 100,000 person-years and 1.1 over the last 5 years. Since 1966, the cumulative incidence rate of ILS over the past 50 years was 0.26 per 100,000 person-years. The median age at diagnosis was 60 years (interquartile ranges, 39–70). Incidence increased with age: over the last 5 years, those aged 60 to 69 exhibited an incidence rate of 2.7 per 100,000 person-years and those 70+ displayed a rate of 4.1. All patients had varying levels of asymmetrical sensorineural hearing loss with 64% of patients presenting with class D hearing. Four (29%) patients had a history of sudden sensorineural hearing loss, five (36%) reported imbalance and/or vertigo, and four (29%) reported aural fullness. Three of the 14 (21%) patients had neurofibromatosis type 2. Conclusion: The incidence of ILS exceeds 1 per 100,000 person-years with modern diagnostic imaging. The rising incidence of ILS in recent years most likely reflects improved capacity for disease detection rather than a true increase in tumor development. Given the reputability of the REP consortium, these data suggest that ILS comprises a more common entity than previously considered.
String Technique for Anterior Orbital Fish Hook Removal
Starr, Matthew R. , Choi, Michael B., Mahr, Michael A. , Mettu, Pradeep, Patterson, David F., Starr, Matthew R

Mayo Clinic

Ophthalmic Plastic & Reconstructive Surgery | June 14, 2018 | Volume: 34 | Issue: 4 | Pages: e136-e137

10.1097/iop.0000000000001157 | PMID 29905635 Get It

Removing fish hooks is a common procedure performed by many emergency department providers. There are several techniques that are commonly employed to aid in successful removal. However, when a fish hook becomes embedded within the orbit, there are limited options as to avoid damaging vital surrounding structures. The authors report the removal of a fish hook within the anterior orbit using the string technique in a 25-year-old patient. The procedure was performed under general anesthesia with the aid of size 5 polyglactin suture wrapped around the hook. The procedure itself took less than 10 seconds and was successful in swiftly and safely removing the hook without damaging surrounding orbital structures. The patient recovered well without any permanent sequelae.